DK2101796T3 - Bacillus smithii stamme TBM112 MSCL P737 og anvendelse af endosporer deraf som probiotikum eller kosttilskud - Google Patents
Bacillus smithii stamme TBM112 MSCL P737 og anvendelse af endosporer deraf som probiotikum eller kosttilskudInfo
- Publication number
- DK2101796T3 DK2101796T3 DK07817985.0T DK07817985T DK2101796T3 DK 2101796 T3 DK2101796 T3 DK 2101796T3 DK 07817985 T DK07817985 T DK 07817985T DK 2101796 T3 DK2101796 T3 DK 2101796T3
- Authority
- DK
- Denmark
- Prior art keywords
- endospores
- probiotics
- mscl
- tbm112
- supplements
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/742—Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/07—Bacillus
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Zoology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Genetics & Genomics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biochemistry (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Food Science & Technology (AREA)
- Immunology (AREA)
- Communicable Diseases (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Nutrition Science (AREA)
- Oncology (AREA)
- Polymers & Plastics (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Fodder In General (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EEP200600038A EE05459B1 (et) | 2006-12-08 | 2006-12-08 | Sporogeense Bacillus smithii tvi TBMI12 MSCL P737 ja selle endospooride kasutamine probiootikumina, toidulisandina ning probiootiline kompositsioon |
| PCT/EE2007/000021 WO2008067827A1 (en) | 2006-12-08 | 2007-10-08 | Bacillus smithii strain tbmi12 mscl p737 and use of endospores thereof as a probiotic or a food supplement |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK2101796T3 true DK2101796T3 (da) | 2012-02-13 |
Family
ID=38921740
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK07817985.0T DK2101796T3 (da) | 2006-12-08 | 2007-10-08 | Bacillus smithii stamme TBM112 MSCL P737 og anvendelse af endosporer deraf som probiotikum eller kosttilskud |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP2101796B1 (da) |
| AT (1) | ATE533499T1 (da) |
| DK (1) | DK2101796T3 (da) |
| EE (1) | EE05459B1 (da) |
| ES (1) | ES2374082T3 (da) |
| RU (1) | RU2439145C2 (da) |
| UA (1) | UA99450C2 (da) |
| WO (1) | WO2008067827A1 (da) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2509149C1 (ru) * | 2012-08-31 | 2014-03-10 | Общество с ограниченной ответственностью "НОВА" | ШТАММ Bacillus subtilis subsp. Subtilis ВКМ В-2711D, ОБЛАДАЮЩИЙ ВЫРАЖЕННЫМ АНТАГОНИЗМОМ ПО ОТНОШЕНИЮ К Escherichia coli, Salmonella typhi, Staphylococcus aureus, Listeria monocytogenes И РЕЗИСТЕНТНОСТЬЮ К СТРЕПТОМИЦИНУ И ТЕТРАЦИКЛИНУ |
| US8906668B2 (en) | 2012-11-23 | 2014-12-09 | Seres Health, Inc. | Synergistic bacterial compositions and methods of production and use thereof |
| NZ709392A (en) * | 2012-11-23 | 2016-10-28 | Seres Therapeutics Inc | Synergistic bacterial compositions and methods of production and use thereof |
| US11185562B2 (en) | 2013-02-04 | 2021-11-30 | Seres Therapeutics, Inc. | Compositions and methods for inhibition of pathogenic bacterial growth |
| EP3904502A3 (en) | 2013-02-04 | 2022-02-23 | Seres Therapeutics, Inc. | Compositions and methods |
| HK1220326A1 (zh) | 2013-03-15 | 2017-05-05 | Seres Therapeutics, Inc. | 基於网络微生物组成和方法 |
| MX367109B (es) | 2013-11-25 | 2019-08-05 | Seres Therapeutics Inc | Composiciones bacterianas sinergicas y sus metodos de produccion y usos. |
| WO2015095241A2 (en) | 2013-12-16 | 2015-06-25 | Seres Health, Inc. | Bacterial compositions and methods of use thereof for treatment of immune system disorders |
| RS57471B1 (sr) | 2015-12-17 | 2018-09-28 | Institut Za Molekularnu Genetiku I Geneticko Inzenjerstvo Univerzitet U Beogradu | Nova probiotička starter kultura za humanu i animalnu primenu |
| AU2018318132B2 (en) | 2017-08-14 | 2025-06-26 | Seres Therapeutics, Inc. | Compositions and methods for treating cholestatic disease |
| EP3703720A1 (en) | 2017-10-30 | 2020-09-09 | Seres Therapeutics, Inc. | Compositions and methods for treating antibiotic resistance |
| CN114410514B (zh) * | 2021-12-31 | 2024-04-02 | 上海新溢生物科技工程研究中心(有限合伙) | 斯密氏芽孢杆菌及其用途 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1262927B (it) * | 1992-01-14 | 1996-07-22 | Consiglio Nazionale Ricerche | Batteri sporgenti e loro impiego come probiotici |
| ITMI20021800A1 (it) * | 2002-08-07 | 2004-02-08 | Proge Farm Srl | Composizione farmaceutica e/o nutraceutica comprendente una associazione di microorganismi probiotici non sporigeni e spore di bacillus subtilis e/o clausii. |
| JP2007518394A (ja) * | 2003-08-14 | 2007-07-12 | ザ バイオ バランス コーポレイション | 細菌菌株、該細菌菌株を含む組成物、およびそのプロバイオティクス使用 |
-
2006
- 2006-12-08 EE EEP200600038A patent/EE05459B1/xx not_active IP Right Cessation
-
2007
- 2007-10-08 DK DK07817985.0T patent/DK2101796T3/da active
- 2007-10-08 RU RU2009126450/10A patent/RU2439145C2/ru not_active IP Right Cessation
- 2007-10-08 UA UAA200906956A patent/UA99450C2/ru unknown
- 2007-10-08 ES ES07817985T patent/ES2374082T3/es active Active
- 2007-10-08 AT AT07817985T patent/ATE533499T1/de active
- 2007-10-08 WO PCT/EE2007/000021 patent/WO2008067827A1/en not_active Ceased
- 2007-10-08 EP EP07817985A patent/EP2101796B1/en not_active Not-in-force
Also Published As
| Publication number | Publication date |
|---|---|
| EP2101796B1 (en) | 2011-11-16 |
| EP2101796A1 (en) | 2009-09-23 |
| WO2008067827A1 (en) | 2008-06-12 |
| UA99450C2 (ru) | 2012-08-27 |
| RU2009126450A (ru) | 2011-01-20 |
| EE05459B1 (et) | 2011-08-15 |
| EE200600038A (et) | 2008-08-15 |
| ATE533499T1 (de) | 2011-12-15 |
| RU2439145C2 (ru) | 2012-01-10 |
| ES2374082T3 (es) | 2012-02-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE533499T1 (de) | Bacillus smithii-stamm tbmi12 mscl p737 und verwendung von endosporen davon als probiotisches mittel oder nahrungszusatz | |
| NZ593708A (en) | Compositions comprising probiotic and prebiotic components and mineral salts, with lactoferrin | |
| BRPI1010637A2 (pt) | suplementos nutricionais orais compreendendo probióticos | |
| BR112012013571A2 (pt) | composições alimentares para animais de estimação,incluindo probióticos e os métodos de fabricação e á sua uitlização. | |
| ES2477882T3 (es) | Probióticos, IgA secretora e infección | |
| DK1978821T3 (da) | Fremgangsmåde til at modificere tarmflora i dyr | |
| ATE526836T1 (de) | Nährstoffzusammensetzung mit probiotika | |
| MX2021009398A (es) | Composiciones probioticas que comprenden cepas de lactobacillus reuteri y metodos de uso. | |
| MY151204A (en) | Lactobacillus plantarum and uses thereof | |
| WO2009122042A3 (fr) | Souche de lactobacillus rhamnosus | |
| WO2008153655A3 (en) | Compositions and methods useful for modulating immunity, enhancing vaccine efficacy, decreasing morbidity associated with chronic fhv-1 infections, and preventing or treating conjunctivitis | |
| MX2012005524A (es) | Cepa de probioticos bifidobacterium. | |
| WO2009130423A3 (fr) | Nouvelle souche de lactobacillus paracasei subsp. paracasei dotee de proprietes antimicrobiennes et immunomodulatrices | |
| DK1624762T3 (da) | Probiotisk præparat med mindst to mælkesyrebakteriestammer som er i stand til kolonisere mavetarmkanalen, i kombination med at de besidder overlevelsesegenskab, tarmbindende egenskab, en infektionsbeskyttelsesegenskab og en fiberfermenterende egenskab | |
| PT2173196E (pt) | Uso de probi?ticos e fibras para a diarreia | |
| PL1874917T3 (pl) | Kompozycja probiotyczna odpowiednia dla zwierząt | |
| PL2169050T3 (pl) | Sposób wytwarzania niealergizujących hodowli bakterii probiotycznych i ich zastosowanie | |
| ZA200907357B (en) | Hemipteran-and coleopteran-active toxin proteins from bacillus thuringiensis | |
| UA94056C2 (uk) | Застосування специфічних молочнокислих бактерій для одержання імуномодулюючих композицій | |
| BRPI0817090A2 (pt) | Método de cultura e uma espécie bacteriana da família anaplasmataceae, e, composição. | |
| WO2006101486A3 (en) | Bacteriocins and novel bacterial strains | |
| ITMI20041232A1 (it) | Composizione nutraceutica contenente un numero elevato di fermenti lattici utile come sinbiotico | |
| CL2010000391A1 (es) | Producto liofilizado en polvo para biolixiviacion o biooxidacion de minerales mixtos o puros que comprende consorcio microbiano de microorganismos nativos y/o modificados geneticamente que lixivian u oxidan los minerales, y/o compuestos de nutrientes especificos para el consorcio; su metodo de preparacion; y su metodo de aplicacion. | |
| WO2009138618A3 (fr) | Compositions a base de resine silicone, leurs procedes d'obtention et leurs applications | |
| Lavryk | Characteristics of adhesive properties of lactobacillus-clinical isolates and components of biological products |